We have been waiting for this for a year and finally the third quarter ended up showing a nice bump in the performance of small-cap stocks. Both the S&P 500 and Russell 2000 were up since the end of the second quarter, but small-cap stocks outperformed the large-cap stocks by double digits. This is important for hedge funds, which are big supporters of small-cap stocks, because their investors started pulling some of their capital out due to poor recent performance. It is very likely that equity hedge funds will deliver better risk adjusted returns in the second half of this year. In this article we are going to look at how this recent market trend affected the sentiment of hedge funds towards Castlight Health Inc (NYSE:CSLT) , and what that likely means for the prospects of the company and its stock.
Castlight Health Inc (NYSE:CSLT) shares didn’t see a lot of action during the third quarter. Overall, hedge fund sentiment was unchanged. The stock was in 14 hedge funds’ portfolios at the end of September. At the end of this article we will also compare CSLT to other stocks including Arena Pharmaceuticals, Inc. (NASDAQ:ARNA), Landauer, Inc. (NYSE:LDR), and Advaxis, Inc. (NASDAQ:ADXS) to get a better sense of its popularity.
Follow Castlight Health Inc. (NYSE:CSLT)
Follow Castlight Health Inc. (NYSE:CSLT)
At Insider Monkey, we’ve developed an investment strategy that has delivered market-beating returns over the past 12 months. Our strategy identifies the 100 best-performing funds of the previous quarter from among the collection of 700+ successful funds that we track in our database, which we accomplish using our returns methodology. We then study the portfolios of those 100 funds using the latest 13F data to uncover the 30 most popular mid-cap stocks (market caps of between $1 billion and $10 billion) among them to hold until the next filing period. This strategy delivered 18% gains over the past 12 months, more than doubling the 8% returns enjoyed by the S&P 500 ETFs.
Jirsak/Shutterstock.com
Keeping this in mind, let’s take a peek at the key action regarding Castlight Health Inc (NYSE:CSLT).
How have hedgies been trading Castlight Health Inc (NYSE:CSLT)?
Heading into the fourth quarter of 2016, a total of 14 of the hedge funds tracked by Insider Monkey were bullish on this stock, flat from the previous quarter. By comparison, 15 hedge funds held shares or bullish call options in CSLT heading into this year. With the smart money’s positions undergoing their usual ebb and flow, there exists a few key hedge fund managers who were boosting their stakes meaningfully (or already accumulated large positions).
When looking at the institutional investors followed by Insider Monkey, Maverick Capital, led by Lee Ainslie, holds the largest position in Castlight Health Inc (NYSE:CSLT). Maverick Capital has a $4.9 million position in the stock, comprising 0.1% of its 13F portfolio. Sitting at the No. 2 spot is Renaissance Technologies, one of the largest hedge funds in the world, which holds a $3.3 million position; less than 0.1% of its 13F portfolio is allocated to the company. Other professional money managers that hold long positions contain Anand Parekh’s Alyeska Investment Group, D. E. Shaw’s D E Shaw and Brian Ashford-Russell and Tim Woolley’s Polar Capital. We should note that none of these hedge funds are among our list of the 100 best performing hedge funds which is based on the performance of their 13F long positions in non-microcap stocks.
